ARTICLE | Company News
CELG, NVS get Ritalin LA approvable letter
October 2, 2001 7:00 AM UTC
Celgene (CELG) and partner Novartis (NVS; SWX:NOVN) received an approvable letter from the FDA for Ritalin LA methylphenidate to treat attention deficit hyperactivity disorder (ADHD). Ritalin LA is a ...